Selected research
Market Outlook & Growth Opportunities
Global Bioanalytical and Testing Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Bioanalytical and Testing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Bioanalytical and Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Bioanalytical and Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bioanalytical and Testing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Bioanalytical and Testing Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Bioanalytical and Testing Services market include Eurofins Scientific, Charles River, LabCorp, Altasciences, Intertek, Celerion, ACM Global Laboratories, Q2 Solutions and WuXi AppTec, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Bioanalytical and Testing Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bioanalytical and Testing Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bioanalytical and Testing Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bioanalytical and Testing Services market.
Bioanalytical and Testing Services Segment by Company
Eurofins Scientific
Charles River
LabCorp
Altasciences
Intertek
Celerion
ACM Global Laboratories
Q2 Solutions
WuXi AppTec
SGS
Ardena
VTT
ICON
Simbec-Orion
Medpace
Frontage
Pharmaron
Veeda
GenScript
Sino Biological
Tigermed
Medicilon
Scinovo
Bioanalytical and Testing Services Segment by Type
Small Molecule Bioanalysis
Large Molecule Bioanalysis
Biomarkers
Biologics and Vaccines
Bioanalytical and Testing Services Segment by Application
Clinical
Non-clinical
Bioanalytical and Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Bioanalytical and Testing Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Bioanalytical and Testing Services key companies, revenue, market share, and recent developments.
3. To split the Bioanalytical and Testing Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Bioanalytical and Testing Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Bioanalytical and Testing Services significant trends, drivers, influence factors in global and regions.
6. To analyze Bioanalytical and Testing Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioanalytical and Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioanalytical and Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioanalytical and Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bioanalytical and Testing Services industry.
Chapter 3: Detailed analysis of Bioanalytical and Testing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Bioanalytical and Testing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Bioanalytical and Testing Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Small Molecule Bioanalysis
- Large Molecule Bioanalysis
- Biomarkers
- Biologics and Vaccines
Applications
- Clinical
- Non-clinical
Companies covered
- Eurofins Scientific
- Charles River
- LabCorp
- Altasciences
- Intertek
- Celerion
- ACM Global Laboratories
- Q2 Solutions
- WuXi AppTec
- SGS
- Ardena
- VTT
- ICON
- Simbec-Orion
- Medpace
- Frontage
- Pharmaron
- Veeda
- GenScript
- Sino Biological
- Tigermed
- Medicilon
- Scinovo
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Bioanalytical and Testing Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Bioanalytical and Testing Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Bioanalytical and Testing Services Market Dynamics
- 2.1 Bioanalytical and Testing Services Industry Trends
- 2.2 Bioanalytical and Testing Services Industry Drivers
- 2.3 Bioanalytical and Testing Services Industry Opportunities and Challenges
- 2.4 Bioanalytical and Testing Services Industry Restraints
3 Bioanalytical and Testing Services Market by Company
- 3.1 Global Bioanalytical and Testing Services Company Revenue Ranking in 2025
- 3.2 Global Bioanalytical and Testing Services Revenue by Company (2021-2026)
- 3.3 Global Bioanalytical and Testing Services Company Ranking (2024-2026)
- 3.4 Global Bioanalytical and Testing Services Company Manufacturing Base and Headquarters
- 3.5 Global Bioanalytical and Testing Services Company Product Type and Application
- 3.6 Global Bioanalytical and Testing Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Bioanalytical and Testing Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Bioanalytical and Testing Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Bioanalytical and Testing Services Market by Type
- 4.1 Bioanalytical and Testing Services Type Introduction
- 4.1.1 Small Molecule Bioanalysis
- 4.1.2 Large Molecule Bioanalysis
- 4.1.3 Biomarkers
- 4.1.4 Biologics and Vaccines
- 4.2 Global Bioanalytical and Testing Services Sales Value by Type
- 4.2.1 Global Bioanalytical and Testing Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Bioanalytical and Testing Services Sales Value by Type (2021-2032)
- 4.2.3 Global Bioanalytical and Testing Services Sales Value Share by Type (2021-2032)
5 Bioanalytical and Testing Services Market by Application
- 5.1 Bioanalytical and Testing Services Application Introduction
- 5.1.1 Clinical
- 5.1.2 Non-clinical
- 5.2 Global Bioanalytical and Testing Services Sales Value by Application
- 5.2.1 Global Bioanalytical and Testing Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Bioanalytical and Testing Services Sales Value by Application (2021-2032)
- 5.2.3 Global Bioanalytical and Testing Services Sales Value Share by Application (2021-2032)
6 Bioanalytical and Testing Services Regional Value Analysis
- 6.1 Global Bioanalytical and Testing Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bioanalytical and Testing Services Sales Value by Region (2021-2032)
- 6.2.1 Global Bioanalytical and Testing Services Sales Value by Region: 2021-2026
- 6.2.2 Global Bioanalytical and Testing Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bioanalytical and Testing Services Sales Value (2021-2032)
- 6.3.2 North America Bioanalytical and Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Bioanalytical and Testing Services Sales Value (2021-2032)
- 6.4.2 Europe Bioanalytical and Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Bioanalytical and Testing Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Bioanalytical and Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Bioanalytical and Testing Services Sales Value (2021-2032)
- 6.6.2 South America Bioanalytical and Testing Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Bioanalytical and Testing Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Bioanalytical and Testing Services Sales Value Share by Country, 2025 VS 2032
7 Bioanalytical and Testing Services Country-level Value Analysis
- 7.1 Global Bioanalytical and Testing Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Bioanalytical and Testing Services Sales Value by Country (2021-2032)
- 7.2.1 Global Bioanalytical and Testing Services Sales Value by Country (2021-2026)
- 7.2.2 Global Bioanalytical and Testing Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Bioanalytical and Testing Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Bioanalytical and Testing Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Bioanalytical and Testing Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Eurofins Scientific
- 8.1.1 Eurofins Scientific Company Information
- 8.1.2 Eurofins Scientific Business Overview
- 8.1.3 Eurofins Scientific Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Eurofins Scientific Bioanalytical and Testing Services Product Portfolio
- 8.1.5 Eurofins Scientific Recent Developments
- 8.2 Charles River
- 8.2.1 Charles River Company Information
- 8.2.2 Charles River Business Overview
- 8.2.3 Charles River Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.2.4 Charles River Bioanalytical and Testing Services Product Portfolio
- 8.2.5 Charles River Recent Developments
- 8.3 LabCorp
- 8.3.1 LabCorp Company Information
- 8.3.2 LabCorp Business Overview
- 8.3.3 LabCorp Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.3.4 LabCorp Bioanalytical and Testing Services Product Portfolio
- 8.3.5 LabCorp Recent Developments
- 8.4 Altasciences
- 8.4.1 Altasciences Company Information
- 8.4.2 Altasciences Business Overview
- 8.4.3 Altasciences Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.4.4 Altasciences Bioanalytical and Testing Services Product Portfolio
- 8.4.5 Altasciences Recent Developments
- 8.5 Intertek
- 8.5.1 Intertek Company Information
- 8.5.2 Intertek Business Overview
- 8.5.3 Intertek Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Intertek Bioanalytical and Testing Services Product Portfolio
- 8.5.5 Intertek Recent Developments
- 8.6 Celerion
- 8.6.1 Celerion Company Information
- 8.6.2 Celerion Business Overview
- 8.6.3 Celerion Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.6.4 Celerion Bioanalytical and Testing Services Product Portfolio
- 8.6.5 Celerion Recent Developments
- 8.7 ACM Global Laboratories
- 8.7.1 ACM Global Laboratories Company Information
- 8.7.2 ACM Global Laboratories Business Overview
- 8.7.3 ACM Global Laboratories Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.7.4 ACM Global Laboratories Bioanalytical and Testing Services Product Portfolio
- 8.7.5 ACM Global Laboratories Recent Developments
- 8.8 Q2 Solutions
- 8.8.1 Q2 Solutions Company Information
- 8.8.2 Q2 Solutions Business Overview
- 8.8.3 Q2 Solutions Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Q2 Solutions Bioanalytical and Testing Services Product Portfolio
- 8.8.5 Q2 Solutions Recent Developments
- 8.9 WuXi AppTec
- 8.9.1 WuXi AppTec Company Information
- 8.9.2 WuXi AppTec Business Overview
- 8.9.3 WuXi AppTec Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.9.4 WuXi AppTec Bioanalytical and Testing Services Product Portfolio
- 8.9.5 WuXi AppTec Recent Developments
- 8.10 SGS
- 8.10.1 SGS Company Information
- 8.10.2 SGS Business Overview
- 8.10.3 SGS Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.10.4 SGS Bioanalytical and Testing Services Product Portfolio
- 8.10.5 SGS Recent Developments
- 8.11 Ardena
- 8.11.1 Ardena Company Information
- 8.11.2 Ardena Business Overview
- 8.11.3 Ardena Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.11.4 Ardena Bioanalytical and Testing Services Product Portfolio
- 8.11.5 Ardena Recent Developments
- 8.12 VTT
- 8.12.1 VTT Company Information
- 8.12.2 VTT Business Overview
- 8.12.3 VTT Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.12.4 VTT Bioanalytical and Testing Services Product Portfolio
- 8.12.5 VTT Recent Developments
- 8.13 ICON
- 8.13.1 ICON Company Information
- 8.13.2 ICON Business Overview
- 8.13.3 ICON Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.13.4 ICON Bioanalytical and Testing Services Product Portfolio
- 8.13.5 ICON Recent Developments
- 8.14 Simbec-Orion
- 8.14.1 Simbec-Orion Company Information
- 8.14.2 Simbec-Orion Business Overview
- 8.14.3 Simbec-Orion Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.14.4 Simbec-Orion Bioanalytical and Testing Services Product Portfolio
- 8.14.5 Simbec-Orion Recent Developments
- 8.15 Medpace
- 8.15.1 Medpace Company Information
- 8.15.2 Medpace Business Overview
- 8.15.3 Medpace Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.15.4 Medpace Bioanalytical and Testing Services Product Portfolio
- 8.15.5 Medpace Recent Developments
- 8.16 Frontage
- 8.16.1 Frontage Company Information
- 8.16.2 Frontage Business Overview
- 8.16.3 Frontage Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.16.4 Frontage Bioanalytical and Testing Services Product Portfolio
- 8.16.5 Frontage Recent Developments
- 8.17 Pharmaron
- 8.17.1 Pharmaron Company Information
- 8.17.2 Pharmaron Business Overview
- 8.17.3 Pharmaron Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.17.4 Pharmaron Bioanalytical and Testing Services Product Portfolio
- 8.17.5 Pharmaron Recent Developments
- 8.18 Veeda
- 8.18.1 Veeda Company Information
- 8.18.2 Veeda Business Overview
- 8.18.3 Veeda Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.18.4 Veeda Bioanalytical and Testing Services Product Portfolio
- 8.18.5 Veeda Recent Developments
- 8.19 GenScript
- 8.19.1 GenScript Company Information
- 8.19.2 GenScript Business Overview
- 8.19.3 GenScript Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.19.4 GenScript Bioanalytical and Testing Services Product Portfolio
- 8.19.5 GenScript Recent Developments
- 8.20 Sino Biological
- 8.20.1 Sino Biological Company Information
- 8.20.2 Sino Biological Business Overview
- 8.20.3 Sino Biological Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.20.4 Sino Biological Bioanalytical and Testing Services Product Portfolio
- 8.20.5 Sino Biological Recent Developments
- 8.21 Tigermed
- 8.21.1 Tigermed Company Information
- 8.21.2 Tigermed Business Overview
- 8.21.3 Tigermed Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.21.4 Tigermed Bioanalytical and Testing Services Product Portfolio
- 8.21.5 Tigermed Recent Developments
- 8.22 Medicilon
- 8.22.1 Medicilon Company Information
- 8.22.2 Medicilon Business Overview
- 8.22.3 Medicilon Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.22.4 Medicilon Bioanalytical and Testing Services Product Portfolio
- 8.22.5 Medicilon Recent Developments
- 8.23 Scinovo
- 8.23.1 Scinovo Company Information
- 8.23.2 Scinovo Business Overview
- 8.23.3 Scinovo Bioanalytical and Testing Services Revenue and Gross Margin (2021-2026)
- 8.23.4 Scinovo Bioanalytical and Testing Services Product Portfolio
- 8.23.5 Scinovo Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst